Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)

Abdominal Imaging

Volumn 38, Issue 6, 2013, Pages 1422-1430

  Mazzei, Maria Antonietta ^a   Khader, Leila ^a   Cirigliano, Alfredo ^a   Cioffi Squitieri, Nevada ^a   Guerrini, Susanna ^a   Forzoni, Beatrice ^a   Marrelli, Daniele ^a   Roviello, Franco ^a   Mazzei, Francesco Giuseppe ^b   Volterrani, Luca ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Cancer diagnosis; Hyperthermic intraperitoneal chemotherapy; Multi detector computed tomography (MDCT); Ovarian cancer; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; MITOMYCIN;

ACCURACY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOLOGY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MEDICAL DEVICE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PERITONEAL CANCER INDEX; PERITONECTOMY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGIST; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CONTRAST MEDIA; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; IOPAMIDOL; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84890116194     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-013-0013-9     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
2. Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198-206
3. Seton-Rogers S (2013) Ovarian cancer: at the starting line. Nat Rev Cancer. doi: 10.1038/nrc3510
4. Nougaret S, Addley HC, Colombo PE, et al. (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32:1775-1800. doi: 10.1148/rg.326125511
5. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219-228
6. Stewart JH 4th (2005) Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12:765-777
7. Roviello F, Caruso S, Marrelli D, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 20:38-54. doi: 10.1016/j.suronc.2010.09.002
8. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
9. Sugarbaker PH (2009) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer. Curr Opin Obstet Gynecol 21:15-24. doi: 10.1097/GCO. 0b013e32831f8f32
10. Roviello F, Pinto E, Corso G, et al. (2010) Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol 102:663-670. doi: 10.1002/jso.21682
11. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374
12. Pfannenberg C, Königsrainer I, Aschoff P, et al. (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int Ann Surg Oncol 16:1295-1303. doi: 10.1245/s10434-009-0387-7
13. Limei Z, Yong C, Yan X, et al. (2013) Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis. Int J Gynecol Cancer 23:598-607
14. Klumpp BD, Aschoff P, Schwenzer N, et al. (2012) Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Imaging 37:834-842
15. 1F]FDG-PET/ CT. Abdom Imaging 35:701-707. doi: 10.1007/s00261-009-9578-8
16. Kim HW, Won KS, Zeon SK, Ahn BC, Gayed IW (2013) Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clin Nucl Med 38:93-97. doi: 10.1097/RLU.0b013e31826390ec
17. Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267-283
18. Roviello F, Marrelli D, Neri A, et al. (2006) Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg 30:2033-2040
19. Sant M, Allemani C, Santaquilani M, et al. (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45:931-991. doi: 10.1016/j.ejca.2008.11.018
20. Verwaal VJ, van Ruth S, de Bree E, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743
21. Bijelic L, Jonson A, Sugarbaker PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943-1950
22. Hamilton T, Lanuke K, Mack LA, Temple WJ (2011) Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg 201:650-654
23. Sala E, Kataoka M, Pandit-Taskar N, et al. (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology 257:125-134
24. Satoh Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447-453
25. De Bree E, Koops W, Kroger R, et al. (2004) Peritoneal carcinomatosis from colorectal cancer or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64-73
26. Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495-499
27. Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694-700. doi: 10.1007/s00261-008- 9464-9
28. Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol 174:1005-1008
29. Mazzei MA, Cioffi Squitieri N, Sani E, et al. (2013) Differences in perfusion CT parameter values with commercial software upgrades: a preliminary report about algorithm consistency and stability. Acta Radiol. doi: 10.1177/0284185113484643.